MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,426 | -89.9% | 42,068 | -73.8% | 0.00% | -100.0% |
| Q2 2023 | $527,397 | +6013.3% | 160,303 | +7537.1% | 0.00% | – |
| Q1 2023 | $8,627 | +72.5% | 2,099 | +182.9% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 742 | -63.3% | 0.00% | – |
| Q2 2022 | $9,000 | -87.5% | 2,023 | -88.8% | 0.00% | – |
| Q1 2022 | $72,000 | +800.0% | 18,123 | +1269.8% | 0.00% | – |
| Q4 2021 | $8,000 | -77.8% | 1,323 | -65.6% | 0.00% | – |
| Q3 2021 | $36,000 | -75.0% | 3,849 | -56.6% | 0.00% | – |
| Q1 2021 | $144,000 | +34.6% | 8,870 | +121.4% | 0.00% | – |
| Q4 2020 | $107,000 | – | 4,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |